Boston Scientific agreed to pay Johnson & Johnson $600 million in connection with Johnson & Johnson’s botched acquisition of Guidant, a medical device company, in 2004.

A high-level overview of Boston Scientific Corporation (BSX) stock. View (BSX) real-time stock price, chart, news, analysis, analyst reviews and more.

Review quarterly and annual revenue, net income, and cash flow for Boston Scientific Corp (BSX:XNYS) stock through the last fiscal year.

Not for distribution to United States newswire services or for dissemination in the United States TORONTO, ON / ACCESS ...

This is an excerpt of the original article. It was written for the July-August 2025 edition of Supply Chain Management Review. The full article is available to current subscribers. Already have a ...

The Triangle Business Journal features local business news about Raleigh/Durham. We also provide tools to help businesses grow, network and hire.

Greek geometry wasn’t just math—it was an attempt to decode the universe. Its logic still powers rockets, bridges, and every ...

Meghan Bartels is a science journalist based in New York City. She joined Scientific American in 2023 and is now a senior news reporter there. Previously, she spent more than four years as a ...

The Secretary-General's Scientific Advisory Board and its associated global network of scientific institutions advise UN leaders on breakthroughs in science and technology – how to harness the ...

Porzingis struggled to play during Boston's second-round NBA playoff series versus the Knicks due to illness. Yahoo Sports. NBA & Fantasy Basketball Loser Lineup: ...